News
MGC Pharmaceuticals (ASX: MXC) has changed its name to Argent Biopharma - RGT (ASX: RGT).
Below are the previous articles from MGC Pharmaceuticals (ASX: MXC):
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Firebrick to start Phase 3 trial on common cold spray, MGC Pharma surges 30pc on FDA listing
Health & Biotech
A huge leap for MGC Pharma as Covid-19 spray ArtemiC is included in the FDA’s National Drug Code Database
News
Top 10 at 10: Which gold junior is up 120pc after signing a US$300m funding facility?
Health & Biotech
Weed Week: BOD advances Aqua Phase acquisition with stability testing
Health & Biotech
ASX Health Stocks: Emyria partners with Pax Centre to provide psychedelics therapy for PTSD sufferers
Health & Biotech
ASX Health Stocks: MGC Pharma passes final hurdle before FDA submission; patents for Recce and AdAlta
News
Market Highlights: ASX to kick off 2023 on a high note, and 5 small caps to watch on Tuesday
Health & Biotech
ASX Health Stocks: NSB files patent in Australia, Cronos ships one-millionth medicinal cannabis unit
News
Market Highlights: Blowout US jobs data, OPEC’s call, and 5 ASX small caps to watch on Monday
Health & Biotech
ASX Biotech Stocks: Estia picks up 4 new aged care homes; MGC flags positive result for long COVID symptoms
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: Aussies are up but Hong Kong sinks in a mixed up regional day
Explainers
ASX Cannabis Stocks Guide 2022/23: Here’s everything you need to know
Health & Biotech
Weed Week: Greens push hard to legalise cannabis and Cronos has 3% of Aussie GPs on its platform already
Health & Biotech
Interim results show MGC Pharma’s CimetrA dose finding study on right track
Health & Biotech
Weed Week: Legal use of medicinal cannabis in Australia on the rise, Lambert Initiative says
Health & Biotech